Rosella Cavarretta

803 total citations
16 papers, 580 citations indexed

About

Rosella Cavarretta is a scholar working on Pathology and Forensic Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Rosella Cavarretta has authored 16 papers receiving a total of 580 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pathology and Forensic Medicine, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Rosella Cavarretta's work include Multiple Sclerosis Research Studies (13 papers), Polyomavirus and related diseases (4 papers) and Herpesvirus Infections and Treatments (3 papers). Rosella Cavarretta is often cited by papers focused on Multiple Sclerosis Research Studies (13 papers), Polyomavirus and related diseases (4 papers) and Herpesvirus Infections and Treatments (3 papers). Rosella Cavarretta collaborates with scholars based in Italy, France and Switzerland. Rosella Cavarretta's co-authors include Domenico Caputo, Carlo Ferrarese, L. Frattola, M. Frigo, C Zoia, Maria Grazia De Simoni, Federica Sarinella, Barbara Begni, Paolo Mascarucci and Pasquale Ferrante and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Cerebral Blood Flow & Metabolism and Neuropharmacology.

In The Last Decade

Rosella Cavarretta

16 papers receiving 557 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rosella Cavarretta Italy 12 204 148 147 112 99 16 580
G. Androdias France 9 121 0.6× 153 1.0× 145 1.0× 75 0.7× 101 1.0× 17 723
А. А. Скоромец Russia 8 106 0.5× 133 0.9× 109 0.7× 89 0.8× 89 0.9× 54 545
Paola Naldi Italy 17 266 1.3× 182 1.2× 72 0.5× 48 0.4× 93 0.9× 41 726
Margarete M. Voortman Austria 9 173 0.8× 91 0.6× 168 1.1× 76 0.7× 30 0.3× 14 674
Falk Steffen Germany 13 255 1.3× 67 0.5× 97 0.7× 59 0.5× 52 0.5× 42 555
Jonas Graf Germany 17 294 1.4× 92 0.6× 141 1.0× 39 0.3× 77 0.8× 41 775
Paola Basilico Italy 13 134 0.7× 74 0.5× 64 0.4× 51 0.5× 85 0.9× 37 490
Małgorzata Bilińska Poland 18 280 1.4× 68 0.5× 99 0.7× 38 0.3× 275 2.8× 78 792
Hiroyoshi Iguchi Japan 14 89 0.4× 227 1.5× 133 0.9× 62 0.6× 35 0.4× 84 1.1k
Francesca Vitetta Italy 18 288 1.4× 68 0.5× 103 0.7× 182 1.6× 99 1.0× 36 744

Countries citing papers authored by Rosella Cavarretta

Since Specialization
Citations

This map shows the geographic impact of Rosella Cavarretta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosella Cavarretta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosella Cavarretta more than expected).

Fields of papers citing papers by Rosella Cavarretta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosella Cavarretta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosella Cavarretta. The network helps show where Rosella Cavarretta may publish in the future.

Co-authorship network of co-authors of Rosella Cavarretta

This figure shows the co-authorship network connecting the top 25 collaborators of Rosella Cavarretta. A scholar is included among the top collaborators of Rosella Cavarretta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosella Cavarretta. Rosella Cavarretta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Racca, Vittorio, et al.. (2019). Acute Fingolimod Effects on Baroreflex and Cardiovascular Autonomic Control in Multiple Sclerosis. SHILAP Revista de lepidopterología. 11. 3701676505–3701676505. 7 indexed citations
2.
Ghezzi, Angelo, Francesca Bianchi, Simona Bonavita, et al.. (2015). Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances. Neurological Sciences. 37(3). 437–442. 8 indexed citations
3.
Racca, Vittorio, Marco Di Rienzo, Rosella Cavarretta, et al.. (2015). Fingolimod effects on left ventricular function in multiple sclerosis. Multiple Sclerosis Journal. 22(2). 201–211. 17 indexed citations
4.
Laganà, Maria Marcella, Antonia Ceccarelli, Maria Giulia Preti, et al.. (2011). Atlas‐Based Versus Individual‐Based Fiber Tracking of the Corpus Callosum in Patients with Multiple Sclerosis: Reliability and Clinical Correlations. Journal of Neuroimaging. 22(4). 355–364. 5 indexed citations
5.
Bavera, P., et al.. (2011). Venous extracranial duplex ultrasound and possible correlations between multiple sclerosis and CCSVI : an observational study after 560 exams. 12(2). 109–113. 3 indexed citations
6.
Mancuso, Roberta, Ambra Hernis, Rosella Cavarretta, et al.. (2010). Detection of viral DNA sequences in the cerebrospinal fluid of patients with multiple sclerosis. Journal of Medical Virology. 82(6). 1051–1057. 36 indexed citations
7.
Arpaia, Guido, P. Bavera, Domenico Caputo, et al.. (2009). Risk of deep venous thrombosis (DVT) in bedridden or wheelchair-bound multiple sclerosis patients: A prospective study. Thrombosis Research. 125(4). 315–317. 44 indexed citations
8.
Saresella, Marina, Alexandre Rolland, Ivana Marventano, et al.. (2009). Multiple sclerosis-associated retroviral agent (MSRV)-stimulated cytokine production in patients with relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal. 15(4). 443–447. 40 indexed citations
9.
Gironi, M., Filippo Martinelli Boneschi, Paola Sacerdote, et al.. (2008). A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis. Multiple Sclerosis Journal. 14(8). 1076–1083. 66 indexed citations
10.
Oreja‐Guevara, Celia, Arnaud Charil, Domenico Caputo, et al.. (2006). Magnetization Transfer Magnetic Resonance Imaging and Clinical Changes in Patients With Relapsing-Remitting Multiple Sclerosis. Archives of Neurology. 63(5). 736–736. 26 indexed citations
11.
Charil, Arnaud, Domenico Caputo, Rosella Cavarretta, et al.. (2006). Cervical cord magnetization transfer ratio and clinical changes over 18 months in patients with relapsing-remitting multiple sclerosis: a preliminary study. Multiple Sclerosis Journal. 12(5). 662–665. 16 indexed citations
12.
Cavaletti, Guido, Paolo Perseghin, Maria Dassi, et al.. (2006). Extracorporeal photochemotherapy: a safety and tolerability pilot study with preliminary efficacy results in refractory relapsing-remitting multiple sclerosis. Neurological Sciences. 27(1). 24–32. 27 indexed citations
13.
Oreja‐Guevara, Celia, Marco Rovaris, Giuseppe Iannucci, et al.. (2005). Progressive Gray Matter Damage in Patients With Relapsing-Remitting Multiple Sclerosis. Archives of Neurology. 62(4). 578–578. 80 indexed citations
14.
Saresella, Marina, Ivana Marventano, Livianna Speciale, et al.. (2005). Programmed cell death of myelin basic protein-specific T lymphocytes is reduced in patients with acute multiple sclerosis. Journal of Neuroimmunology. 166(1-2). 173–179. 17 indexed citations
15.
Ferrarese, Carlo, Paolo Mascarucci, C Zoia, et al.. (1999). Increased Cytokine Release from Peripheral Blood Cells after Acute Stroke. Journal of Cerebral Blood Flow & Metabolism. 19(9). 1004–1009. 172 indexed citations
16.
Ferrarese, Carlo, M. Perego, Rosella Cavarretta, et al.. (1995). Effect of anticonvulsant drugs on peripheral benzodiazepine receptors of human lymphocytes. Neuropharmacology. 34(4). 427–431. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. Androdias Breakdown of academic impact, for papers by А. А. Скоромец Breakdown of academic impact, for papers by Paola Naldi Breakdown of academic impact, for papers by Margarete M. Voortman Breakdown of academic impact, for papers by Falk Steffen Breakdown of academic impact, for papers by Jonas Graf Breakdown of academic impact, for papers by Paola Basilico Breakdown of academic impact, for papers by Małgorzata Bilińska Breakdown of academic impact, for papers by Hiroyoshi Iguchi Breakdown of academic impact, for papers by Francesca Vitetta
Rankless by CCL
2026